Collegium Pharma (COLL) – Analyst Ratings
-
Jefferies Downgrades Collegium Pharmaceutical (COLL) to Hold, 'Well-Played Cap Deployment Strategy Yields Windfall for Investors'
-
Jefferies Assumes Collegium Pharmaceutical (COLL) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to COLL Stock Lookup